Please login to the form below

Not currently logged in
Email:
Password:

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

J&J could launch its single-dose COVID-19 vaccine in March

J&J could launch its single-dose COVID-19 vaccine in March

of Allergy and Infectious Diseases (NIAID).

Latest news

More from news
Approximately 4 fully matching, plus 220 partially matching documents found.

Latest Intelligence

  • The pandemic preparedness paradox The pandemic preparedness paradox

    There is no market for sporadic infectious diseases. Even the use of the word ‘market’ is incorrect. ... And we know how to translate academic inventions into medicines that can help patients, but today that’s not happening, because there is no

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious ... Diseases’ (NIAID) placebo-controlled phase

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID). ... IL-6 is a type of cytokine that plays an important role in immune response and is

  • We’ll need more than a spoonful of sugar to counter vaccine hesitancy We’ll need more than a spoonful of sugar to counter vaccine hesitancy

    It is, therefore, critical that action is taken to stop the re-emergence of dangerous infectious diseases.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. ... In 2005, he joined the Novartis Institutes for

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics